Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
about
Histological and molecular evaluation of patient-derived colorectal cancer explantsAn integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcomaPatient-derived tumour xenografts as models for oncology drug developmentPatient-derived tumor xenografts: transforming clinical samples into mouse modelsPatient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewAn Integrative Approach to Precision Cancer Medicine Using Patient-Derived XenograftsPatient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatmentPreclinical Murine Models for Lung Cancer: Clinical Trial ApplicationsAntibody Drug Conjugates: Preclinical ConsiderationsOne mouse, one patient paradigm: New avatars of personalized cancer therapyCurrent status and evolution of preclinical drug development models of epithelial ovarian cancerPatient-derived xenografts: a relevant preclinical model for drug developmentGenetically engineered mouse models in oncology research and cancer medicinePrioritizing therapeutic targets using patient-derived xenograft modelsAssessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastasesPromoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenograftsFrom bench to bedside: lessons learned in translating preclinical studies in cancer drug developmentIntegrated analysis of transcriptome in cancer patient-derived xenograftsHistone acetyltransferase inhibitors block neuroblastoma cell growth in vivoUsing heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerHuman solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.The future of patient-derived tumor xenografts in cancer treatment.Human tumor xenograft models for preclinical assessment of anticancer drug development.Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models.Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsyEstablishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasisStability of preclinical models of aggressive renal cell carcinomas.A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsiesRadiogenomics predicting tumor responses to radiotherapy in lung cancerPatient-derived xenograft models: an emerging platform for translational cancer researchAre all cancer stem cells created equal?Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient miceGene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer.Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.A new mouse avatar model of non-small cell lung cancer.Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor GroupThe extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice
P2860
Q21134541-3B45F09A-4E7D-4CAF-892B-830ABB060C3DQ21198840-A8D83325-F634-4BFE-826E-A0B69D30D24DQ24604068-CFF5B83F-ABAD-418B-84F6-DBB04B1FDF3EQ24627425-C51E6E0A-9A9F-4A50-A4F7-856785A8FF5DQ26741651-A371928F-5A82-4967-B4A7-2ADFB503DC5AQ26772895-E68FC756-56CB-4852-828B-EB673F339294Q26829125-5AF14F86-1B6B-4148-AF55-8912B3AA6A81Q26863474-BF8F91DC-6BDC-4A94-AD11-AA0BF5D41292Q27022321-0A0073DF-3522-409A-84FD-2690409BEC57Q27023342-57A17A43-E0D7-485B-A7EF-3DDA3832261EQ27028117-FF050866-55C6-4F1E-8F99-DD1F0CB55783Q28067191-2B0EFC00-539A-4418-B986-27D303189F5FQ28079323-963DFAA8-C73C-406C-B034-4634C2F0CE21Q28083993-3D9065E5-91A5-45FD-A349-C34D3D48AB67Q28478248-98EB75D7-48E9-454E-8093-AF28AE66C848Q28478302-72D07B36-8FD4-42B6-A652-194186523304Q28533949-143C22D2-EF89-41F2-AC4E-398C0A895DB5Q28547069-0333C5CE-D48E-464A-985C-20E358CCFAF0Q30316789-5C354900-5A83-4224-95A2-77DC72D52369Q30409503-AC4E2DAC-86BB-4D80-B90E-8DD69CCF0A18Q31068871-E9C0DD34-501A-489F-878E-961B4E173EEAQ33361578-E81A4706-2393-4046-9C55-2E1B79E0846CQ33554319-76FBBAA3-2D6B-4744-A891-CA667134070BQ33756818-08C302A8-9C73-4A26-9EE0-085D709A339DQ33758978-6DC0739E-7FAD-4C94-93DF-A2895B1B47EDQ33779673-E92AC3CD-BDD7-44B9-A5BF-507C5C35F8ECQ33821373-745047DB-0C65-4E6B-9F54-3A7CB88CB6AFQ33827461-0C15B987-4108-4591-9F49-027A0AA23B7BQ33898564-8FDABF2B-652E-4FCD-9CD5-A06C85C3F2FDQ34024820-4D6833D8-3218-46D8-87CC-2DF64396F0BDQ34049363-F17D6C3D-9671-4246-BE83-0DC391EF66FDQ34205518-EE3B292F-B2B3-4AB0-A7E2-E8581E3ED96FQ34273110-64ABD76F-FBD4-4657-96F9-56775CB90AB2Q34372342-0C862ACF-CB26-437D-8E8D-DFFB89F355EDQ34994030-D6624EAC-6DD8-4945-84A0-B3F210CDFE4AQ34996167-E07758C0-82DC-4B02-A19B-8C0CA0AF16F7Q35084915-331EB828-F24B-4594-BE19-02107FA824D4Q35141122-EFEE45F0-F603-413A-8C5A-B7A4F59CFE98Q35188488-4554B711-E1C1-4817-A500-2EA170AA97B3Q35227197-AB74A5B8-C8CB-4579-ADF3-EB52E8D5364B
P2860
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Establishment of patient-deriv ...... tion of predictive biomarkers.
@en
Establishment of patient-deriv ...... tion of predictive biomarkers.
@nl
type
label
Establishment of patient-deriv ...... tion of predictive biomarkers.
@en
Establishment of patient-deriv ...... tion of predictive biomarkers.
@nl
prefLabel
Establishment of patient-deriv ...... tion of predictive biomarkers.
@en
Establishment of patient-deriv ...... tion of predictive biomarkers.
@nl
P2093
P921
P1476
Establishment of patient-deriv ...... ation of predictive biomarkers
@en
P2093
Iduna Fichtner
Jana Rolff
Jens Hoffmann
Johannes Merk
Michael Becker
Stefanie Hammer
P304
P356
10.1158/1078-0432.CCR-08-0138
P407
P577
2008-10-01T00:00:00Z